Publications

Robert M. Grant, MD, MPHLiu AY, Grant RM, Buchbinder SP. Preexposure prophylaxis for HIV: unproven promise and potential pitfalls. JAMA. 2006 Aug 16; 296(7):863-5. View in: PubMed
Robert Grant, MD, MPHChemoprophylaxis of HIV infection: moving forward with caution. View in: PubMed
Robert M. Grant, MD, MPHLama JR, Sanchez J, Suarez L, Caballero P, Laguna A, Sanchez JL, Whittington WL, Celum C, Grant RM. Linking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. J Acquir Immune Defic Syndr. 2006 Aug 1; 42(4):501-5. View in: PubMed
Robert Grant, MD, MPHAntiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls. View in: PubMed
Robert M. Grant, MD, MPHSánchez MS, Grant RM, Porco TC, Getz WM. HIV drug-resistant strains as epidemiologic sentinels. Emerg Infect Dis. 2006 Feb; 12(2):191-7. View in: PubMed
Robert Grant, MD, MPHPreexposure prophylaxis for HIV: unproven promise and potential pitfalls. View in: PubMed
Robert M. Grant, MD, MPHGange SJ, Schneider MF, Grant RM, Liegler T, French A, Young M, Anastos K, Wilson TE, Ponath C, Greenblatt R. Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure. J Acquir Immune Defic Syndr. 2006 Jan 1; 41(1):68-74. View in: PubMed
Robert Grant, MD, MPHLinking HIV and antiretroviral drug resistance surveillance in Peru: a model for a third-generation HIV sentinel surveillance. View in: PubMed
Robert Grant, MD, MPHHIV drug-resistant strains as epidemiologic sentinels. View in: PubMed
Robert M. Grant, MD, MPHPapasavvas E, Kostman JR, Thiel B, Pistilli M, Mackiewicz A, Foulkes A, Gross R, Jordan KA, Nixon DF, Grant R, Poulin JF, McCune JM, Mounzer K, Montaner LJ. HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption. J Clin Immunol. 2006 Jan; 26(1):40-54. View in: PubMed